Daiichi Sankyo is committed to bringing pharmaceutical innovation from bench to bedside. Innovation is paramount in all that we do, from pursuing new medicines and new methods of drug discovery and delivery, to achieving excellence throughout our organization.
A fruitful working relationship between the pharmaceutical industry and healthcare professionals has helped develop many life-saving medicines and has long been a positive driver for advancements in patient care and the progression of research.
We fully support transparency and are prepared to disclose proper documentation of all our transfers of value, both to healthcare professionals (HCP) and healthcare organisations (HCO), under the EFPIA Disclosure Code and according country specific applicable laws and regulations.
DSC/22/0124 Date of Prep: June 2022